title: SARS: what have we learned?
authors.forename: Helen
authors.initials: H
authors.lastname: Pearson
authors.forename: Tom
authors.initials: T
authors.lastname: Clarke
authors.forename: Alison
authors.initials: A
authors.lastname: Abbott
authors.forename: Jonathan
authors.initials: J
authors.lastname: Knight
authors.forename: David
authors.initials: D
authors.lastname: Cyranoski
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D002681:China / Q000453:epidemiology; D021821:Communicable Diseases, Emerging / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control; D006285:Health Planning; D006801:Humans; D009154:Mutation; D045473:Severe acute respiratory syndrome-related coronavirus / Q000235:genetics; D045169:Severe Acute Respiratory Syndrome / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control; D014765:Viral Vaccines
chemical_list: D000998:Antiviral Agents; D014765:Viral Vaccines